NCT04008199 is a NA clinical trial of Super Abbu in Maternal and Child Health, sponsored by University of California, Davis.

Who is sponsoring NCT04008199?

NCT04008199 is sponsored by University of California, Davis.

What drugs are being tested in NCT04008199?

Interventions in NCT04008199: Super Abbu.

What condition does NCT04008199 study?

NCT04008199 studies Maternal and Child Health.

Is NCT04008199 still recruiting?

NCT04008199 is currently terminated. Last updated 30 November 2023.

Last reviewed 2023-11-30 · How we verify

NCT04008199

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact Evaluation of Super Abbu: A Speech Based MNCH Platform in Pakistan

Terminated NA Last updated 30 November 2023

What this trial tests

NA trial testing Super Abbu in Maternal and Child Health in 276 participants. Terminated before completion.

Timeline

1 June 2021

Primary endpoint
31 July 2023

31 July 2023

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	276
Start date	1 June 2021
Primary completion	31 July 2023
Estimated completion	31 July 2023
Sites	1 location across Pakistan

Drugs / interventions tested

Super Abbu

Conditions studied

Maternal and Child Health — all drugs for Maternal and Child Health →

Sponsor

University of California, Davis

Who can join

18 and older, any sex, with Maternal and Child Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have developed, piloted, and propose to expand and to experimentally evaluate a speech-based service that connects expectant fathers to doctors and to each other over a simple phone call. This service, dubbed Super Abbu (Super Dad in English), addresses the challenges faced by existing efforts in several new and important ways: * The service targets fathers. Currently, the entire public health infrastructure in Punjab is geared towards providing information to women. * It supplements LHWs by providing information between LHW visits. * It does so in a manner appropriate for those who are illiterate and do not have smartphones. * It does not require synchronous phone calls. Expectant fathers can leave questions to be answered. And they can access past questions and answers asked by themselves and other users. * Through experience developing, publicizing, and driving adoption of speech-based services, the investigators believe they can overcome the slow adoption rate faced by the Punjab Health Line. Principal investigator Raza previously developed and launched Baang in Punjab, an entertainment speech-based social service, similar to Reddit, which accumulated 42,500 calls by 1,550 users within 71 days of its launch. These users listened to 393,448 speech posts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Maternal and Child Health

Currently open trials in the same condition.

NCT03215368 — The Ma'Anshan Birth Cohort (MABC) · active not recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04008199 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 30 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04008199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing